Remote Biotech Jobs (Hiring Now, Jan 2025): Find the best work from home or hybrid full & part-time jobs. Discover a better job search with FlexJobs!
G1 announced that it would “discontinue the anticipated hiring of staff” that had been lined up to roll out the drug in that indication. In order to stick to its ambition of achieving profitability by the second half of 2025, the biotech will also make “targeted headcoun...
mid, small cap companies, when I think about biotech, it is more about development stages, so to me, there are maybe five, distinct development stages, which is reflected by their valuation (broad strokes; there are always exceptions): ...
John and I talked several times on the phone and he was able to find 2 positions in short order that were potentially right for me. He understood what I was saying to him about both my actual skills and my preferred culture. And he knew very well the companies in the Boston area. He...
It allowed me to work in a meaningful space that leveraged my love of engineering and mathematics.” Biotech 40 Biotech Sourcing Strategies Supply Chain Design Software Waste Reduction 40 Why Biotech Companies Use eProcurement ProcurePort NOVEMBER 11, 2021 Today’s biotech industry consists of ...
The startup has 18 full-time staffers and plans to “continue to grow steadily,” aiming to hit about 25 people by the end of the year. The hiring spree will hopefully include bringing on a full-time CEO in the near future, Kotz said. Jnana is currently helmed by Amir Nashat, a par...
Hiring. This would seem to be a big one, especially in hotly competitive geographies such as Cambridge or the Bay Area. But now that more and more “virtual drug development” companies are filing for IPO in Phase 2 with staffs of fewer than fifteen people – two of these have beenCBT ...
That done, Confo has gone on a hiring push, adding staff from lab technicians up to group leaders with industry experience. Confo has focused the first wave of the hiring push on areas such as structural biology and in vitro pharmacology, with a move into in vivo pharmacology and ...
What makes them different from other companies working in this area? “We’re going after personalized approaches both on the vaccine side as well as on the T-cell therapy side, and we are really becoming leaders I think in the space of some of the key components that you need to make ...
to have the right lab behind the company. That kind of scientific credibility is at the heart of many success stories. And as more scientists get bitten by the biotech bug, I'd be willing to wager that you'll see many of them come back to launch more new companies in years to come....